Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

First case of MRSA in UK pig
pig
The risk of MRSA to humans remains very low, according to BVA.
BVA defends use of antibiotics in farming

For the first time in the UK, a piglet in Northern Ireland has been infected with livestock-associated MRSA (LA-MRSA).

According to a letter published in the Veterinary Record, the post-weaning piglet was one of five tested at the Omagh disease surveillance laboratory of the Agri-Food and Biosciences Institute (AFBI) in May this year.

It is the first known case of LA-MRSA in UK pigs. In a joint statement, the BVA and Pig Veterinary Society (PVS) said the MRSA risk to humans remains very low.

The piglet had a history of pneumonia and wasting and there had been 10 per cent piglet mortality on the farm involved over a period of two or three months.

AFBI said the discovery of LA-MRSA in this piglet is considered to be incidental. It is thought the main disease factor in the case was the piglet's infection with the European strain porcine reproductive and respiratory syndrome virus (PRRSV).

Following the announcement, the Alliance to Save our Antibiotics has urged the government to carry out a full survey of the UK pig industry to find out how widespread the superbug is. The group is also calling for immediate restrictions on the farm use of antibiotics deemed “critically important” to human medicine.

BVA and PVS said: “The Alliance to Save our Antibiotics seems to suggest that vets use large amounts of this critically important group of antibiotics. However, the group of antibiotics considered critically important is available for individual animal treatment only and not for mass medication through feed or water.”

Both organisations have issued advice to their members that these groups of drugs should only be used where evidence suggests this is absolutely necessary.

According to current scientific evidence, antibiotic resistance in human medicine is primarily due to antibiotic use in people, not animals. However, BVA and PVS said “any isolation of resistant organisms in food producing animals is of concern.”

However, the organisations added: “It is worth noting that the LA-MRSA found in the pig in Northern Ireland is genetically different from the MRSA strains causing healthcare-associated human infections and it does not spread so readily between humans.”

LA-MRSA was first confirmed in the Netherlands in 2003, when it was linked to pigs, pig farmers and subsequently cattle.

In countries where there is a high prevalence of the superbug, such as the Netherlands, Germany and Denmark, research suggests that people working with livestock are more likely to become infected with MRSA than those with no direct contact with animals.

MRSA is not considered to be a food borne disease and the Food Standards Agency says cooking meat properly should render the risk to consumers negligible.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.